Jump to:
Maggie Toms is an associate in the business restructuring group in Ropes & Gray’s New York office. Her practice focuses on all aspects of corporate restructuring, bankruptcy, and insolvency proceedings, including advising public and private companies, boards, ad hoc groups, and committees in both in-court chapter 11 proceedings and out-of-court restructurings. Maggie’s experience spans a broad range of industries, including technology, life sciences, health care, medical devices, media & entertainment, and retail.
Experience
- Represented Exactech, Inc. and its affiliated debtors in their pending chapter 11 cases involving the restructuring of more than $350 million of prepetition debt, as well as additional prepetition liabilities; Exactech’s chapter 11 cases are supported by an $85 million debtor in possession credit facility and a stalking horse bid, which remains subject to higher and better offers, for substantially all of the debtors’ assets.
- Represented Amylyx Pharmaceuticals, a global pharmaceutical company focused on developing treatments for neurodegenerative diseases, in its successful bid of more than $35.1 million to purchase the avexitide assets of Eiger BioPharmaceuticals, Inc. in the sale of Eiger’s assets pursuant to Section 363 of the bankruptcy code.
- Represented Shoes For Crews, a leading producer of non-slip shoes, in a sale to a group of its secured lenders through voluntary chapter 11 proceedings and in obtaining approximately $30 million in DIP financing from the secured lenders acquiring the business.